ReviewPharmaceutics2023
SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation.
Jasna Klen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it
ReviewPharmaceutics2023
Jasna Klen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.